Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 89.97% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -13.44% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 33.37% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.09% |
| Jun 30, 2025 | 26.76% |
| Mar 31, 2025 | -62.40% |
| Dec 31, 2024 | 43.15% |
| Sep 30, 2024 | -82.77% |
| Jun 30, 2024 | 32.20% |
| Mar 31, 2024 | 26.41% |
| Dec 31, 2023 | -11.44% |
| Sep 30, 2023 | -46.95% |
| Jun 30, 2023 | -60.68% |
| Mar 31, 2023 | -38.40% |
| Dec 31, 2022 | 30.01% |
| Sep 30, 2022 | 10.04% |
| Jun 30, 2022 | -23.08% |
| Mar 31, 2022 | -12.73% |
| Dec 31, 2021 | 4.51% |
| Sep 30, 2021 | 28.37% |
| Jun 30, 2021 | -70.06% |
| Mar 31, 2021 | -62.34% |
| Dec 31, 2020 | -48.38% |